You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》心泰醫療(02291.HK)今起招股 一手入場費31,766.97元
內地結構性心臟病介入醫療器械供應商樂普心泰醫療(02291.HK)公布招股詳情,擬全球發售2,245.5萬股,香港公開發售佔約一成,國際發售佔約九成。每股招股價介乎29.15至31.45元。每手1,000股計,一手入場費31,766.97元。該股今日(10月27日)起招股,下周二(11月1日)中午截止,預期11月8日掛牌。獨家保薦人為中金。 公司上市引入3名基石投資者,包括嘉實國際旗下Harvest、臨港控股(600848.SH)全資附屬臨港及九州通醫藥(600998.SH)全資附屬Jointown International,合共認購2,480萬美元公司股份。 如以招股價中位數30.3元計,是次上市料淨集資約5.92億元,擬於未來五年內,將約50.7%用於研發活動提供資金;約24.3%用於銷售及營銷活動;約5%用於提升產能及加強製造能力;約10%用於潛在的戰略投資及收購提供資金;約10%將用於營運資金及一般公司用途。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account